Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Lakartidningen|May 11, 2021
[Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure]Erik Eliasson, Mia Wadelius
Pharmacogenomics|March 3, 2012
Prediction of warfarin dose: why, when and how?Niclas Eriksson, Mia Wadelius
Genome Medicine|December 30, 2011
Pharmacogenomics and personalized medicine: the plunge into next-generation sequencingMia Wadelius, Ana Alfirevic
Pharmacogenomics|February 19, 2014
Pharmacogenetics-based warfarin dosing in childrenAnna-Karin Hamberg, Mia Wadelius
BMC Blood Disorders|December 4, 2004
Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?Annica Jacobson, Håkan Melhus, Mia Wadelius
European Journal of Clinical Pharmacology|March 21, 2025
Genome-wide association study of direct oral anticoagulants and their relation to bleedingSofia Attelind, Niclas Eriksson, Mia Wadelius, et al.
Lakartidningen|September 9, 2021
[New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings]Alice Schultz, Hugo Kohnke, Mia Wadelius, et al.
European Journal of Clinical Pharmacology|June 14, 2005
Warfarin dose related to apolipoprotein E (APOE) genotypeHugo Kohnke, Kristina Sörlin, Göran Granath, et al.
Assay and Drug Development Technologies|April 20, 2004
Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technologySolveig Eriksson, Lars M Berg, Mia Wadelius, et al.
Drug, Healthcare and Patient Safety|December 13, 2018
Clinical factors predicting drug-induced liver injury due to flucloxacillinMikaela Lindh, Pär Hallberg, Qun-Ying Yue, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Lakartidningen|May 11, 2021
[Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure]Erik Eliasson, Mia Wadelius
Pharmacogenomics|March 3, 2012
Prediction of warfarin dose: why, when and how?Niclas Eriksson, Mia Wadelius
Genome Medicine|December 30, 2011
Pharmacogenomics and personalized medicine: the plunge into next-generation sequencingMia Wadelius, Ana Alfirevic
Pharmacogenomics|February 19, 2014
Pharmacogenetics-based warfarin dosing in childrenAnna-Karin Hamberg, Mia Wadelius
BMC Blood Disorders|December 4, 2004
Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?Annica Jacobson, Håkan Melhus, Mia Wadelius
European Journal of Clinical Pharmacology|March 21, 2025
Genome-wide association study of direct oral anticoagulants and their relation to bleedingSofia Attelind, Niclas Eriksson, Mia Wadelius, et al.
Lakartidningen|September 9, 2021
[New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings]Alice Schultz, Hugo Kohnke, Mia Wadelius, et al.
European Journal of Clinical Pharmacology|June 14, 2005
Warfarin dose related to apolipoprotein E (APOE) genotypeHugo Kohnke, Kristina Sörlin, Göran Granath, et al.
Assay and Drug Development Technologies|April 20, 2004
Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technologySolveig Eriksson, Lars M Berg, Mia Wadelius, et al.
Drug, Healthcare and Patient Safety|December 13, 2018
Clinical factors predicting drug-induced liver injury due to flucloxacillinMikaela Lindh, Pär Hallberg, Qun-Ying Yue, et al.
Pageof 10